Erin Hugger Difilippo

Vice President Of Business Development at Prelude Therapeutics

Erin Hugger DiFilippo has a strong background in business development and scientific licensing, with expertise in a range of therapeutic areas. Erin currently holds the position of Vice President of Business Development at Prelude Therapeutics since September 2022. Prior to that, they worked at Turning Point Therapeutics as the Executive Director of Search & Evaluation, Business Development from January 2022 to September 2022.

From 2015 to 2021, Erin held various roles at Incyte, starting as the Head of Search & Evaluation Business Development from August 2020 to December 2021. Before that, they served as the Vice President of Business Development from June 2015 to August 2020.

Erin also has extensive experience at GSK, where they held multiple positions. Erin worked as the Senior Director of Scientific Licensing & Interim Head of Oncology BD, World-Wide Business Development from January 2014 to May 2015. Prior to that, they were the Director of Scientific Licensing for Infectious Diseases, WWBD from January 2012 to December 2013 and the Director of Scientific Licensing for Rare Diseases, WWBD from February 2010 to January 2012. Erin also served as the Manager of Scientific Licensing, World-Wide Business Development from September 2008 to February 2010. Erin started their career at GSK as an Investigator/Manager of Drug Metabolism & Pharmacokinetics from July 2003 to September 2008 and later became a Principle Scientist in Pharmaceutical Development from October 2001 to July 2003.

Erin's earlier experience includes working as a Graduate Research Assistant at the University of Kansas from January 1998 to October 2001 and a Graduate Student Intern at Pharmacia from July 2000 to April 2001.

Erin Hugger DiFilippo's education history includes earning a Ph.D. in Pharmaceutical Chemistry from The University of Kansas, from 1997 to 2001. Prior to that, they obtained a B.S. in Chemistry with a biochemistry emphasis from The University of Tulsa, spanning from 1993 to 1997. Erin completed their high school education at Claremore High School from 1991 to 1993, though no degree or field of study information is provided for this period.

Links

Previous companies

Incyte logo
Pfizer logo
The University of Kansas logo